As­traZeneca re­joins PhRMA, two years af­ter leav­ing lob­by group

British drug­mak­er As­traZeneca is re­join­ing the drug in­dus­try’s ma­jor US lob­by­ing group, PhRMA, rough­ly two years af­ter quit­ting the or­ga­ni­za­tion.

As part of its mem­ber­ship …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER